IMPLANET announced the clearance of its MADISON total knee prosthesis by the Therapeutic Goods Administration (TGA) for marketing in Australia. This approval is an integrated part of the distribution agreement concluded with KICo in November 2018 for the marketing of the MADISON knee prosthesis, specifically covering the United States and Australia. This new milestone completes the eight international licenses covering the MADISON knee prosthesis range, the FDA 510(k) clearance granted for marketing in the US as well as the CE marking obtained in Europe.